Neurological involvement associated with plasmodium vivax malaria from Pakistan by Khan, Yousaf Abdullah et al.
eCommons@AKU 
Department of Pathology and Laboratory 
Medicine Medical College, Pakistan 
1-2018 
Neurological involvement associated with plasmodium vivax 
malaria from Pakistan 
Yousaf Abdullah Khan 
Aga Khan University 
Usman Hameed Mian 
Aga Khan University 
Najia Karim Ghanchi 
Aga Khan University, najia.ghanchi@aku.edu 
Ali Bin Sarwar Zubairi 
Aga Khan University, ali.zubairi@aku.edu 
Mohammad Asim Beg 
Aga Khan University 
Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_pathol_microbiol 
 Part of the Diseases Commons, Health and Physical Education Commons, Microbiology Commons, 
and the Pathology Commons 
Recommended Citation 
Khan, Y. A., Mian, U. H., Ghanchi, N. K., Zubairi, A., Beg, M. A. (2018). Neurological involvement associated 
with plasmodium vivax malaria from Pakistan. Tropical Doctor, 48(1), 52-54. 
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_pathol_microbiol/723 
1 
 
Neurological involvement associated with Plasmodium vivax malaria from 
Pakistan 
Yousaf Abdullah Khan1,§ ,Usman Hameed Mian1,§, Najia Karim Ghanchi2, Ali Bin 
Sarwar Zubairi3, Mohammad Asim Beg*,2 
§Equal contribution 
1Medical college, Aga Khan University, Karachi, Pakistan 
2Department of Pathology and Laboratory Medicine, Aga Khan University, Stadium 
Road, P.O. Box 3500, Karachi 74800, Pakistan. 
3Department of Medicine, Aga Khan University, Stadium Road, P.O. Box 3500, 
Karachi 74800, Pakistan. 
Short title: Neurological involvement associated with Plasmodium vivax 
Keywords: Cerebral malaria, Plasmodium vivax, gametocytes, seizures. 
*Corresponding author:  Mohammad Asim Beg   masim.beg@aku.edu 
Tel# 00 92 3486 4512 / 00 92 3486 1641 
 
 
  
 
Background: 
Plasmodium vivax is the most common species causing malaria outside Africa with 
approximately 13.8 million reported cases worldwide. More than 80% of P. 
vivax malaria cases are estimated to occur in Pakistan, India and Indonesia (WHO 
2015) .  P.vivax is associated with increased morbidity but reduced mortality when 
compared to Plasmodium falciparum. Recently, studies from Indonesia, Papua New 
Guinea, Brazil, India, and Pakistan have shown that P.vivax, can independently prove 
fatal or result in severe morbidity. The most common complications of vivax malaria 
reported globally are anemia and non-cardiogenic pulmonary oedema/ acute 
respiratory distress syndrome. Other complications are severe thrombocytopenia, 
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pancytopenia, jaundice, splenic rupture, acute renal failure and rarely cerebral 
involvement. 
Cerebral malaria is a known complication of P. falciparum with over 575,000 cases 
leading to neurological, behavioural and cognitive defects reported annually.(1) 
However, cerebral malaria due to P. vivax mono infection is rarely reported. Malaria 
remains an endemic disease in Pakistan with an estimated health care burden of 1.6 
million cases annually with P. vivax accounting for 67% of reported cases. We 
report a severe P. vivax infection with cerebral involvement in a child. 
  
Case Report 
A nine-year old boy presented to the emergency department of The Aga Khan 
University Hospital (AKUH) with a 3-day history of high grade fever accompanied 
by projectile vomiting and abnormal behaviour. A day prior to his admission he 
developed generalized tonic-clonic seizures associated with dizziness and 
unconsciousness. He had a coma score of 5/15 on presentation with a tachycardia 
(167/min), tachypnoea (70 breaths/min), oxygen saturation of 92%, blood pressure of 
133/87 mm of Hg and a temperature of 38oC. There was hypertonia in all limbs. The 
rest of the physical examination was normal. The full blood count showed anaemia 
(Hb 94g/L), a leucocytosis (13.1x106/mL, neutrophils 75% and monocytes 8%) and 
normal platelet count (304x106/mL). A cerebral CT scan showed oedema with 
increased intracranial pressure. Thick and thin peripheral smear with Giemsa stain 
was suggestive of P. vivax with 1-10 per 100 high power fields. Stained blood films 
were also independently reviewed by an external expert parasitologist who confirmed 
the original diagnosis. Polymerase chain reaction (PCR) and an immuno-
chromatography test (ICT) definitely excluded P. falciparum infection.  Prothrombin 
time and activated partial thrombin time were in the normal range, and the direct 
antiglobulin test was negative. Although no lumbar puncture was performed empirical 
therapy for bacterial and viral meningitis was initiated. Initially Vancomycin, 
Meropenem, Acyclovir, steroids and anticonvulsants were started in emergency. 
The patient was mechanically ventilated. He required vasopressor support with 
norepinephrine. Blood cultures and urine cultures were all negative,   Antibiotics were 
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deescalated and stopped as blood film confirmed malarial parasite P.vivax and started 
with artemether lumefantrine. On the third day, he developed high urine output and 
hyponatremia secondary which was managed with fludrocortisone. On presentation 
his sodium levels were 145mmol/L (normal ranges 135-145 mmol/L) and dropped to 
125mmol/L on third day. His sodium level was corrected to 135 in 72 hours and child 
gained consciousness. The GCS score improved to 15/15 and he was extubated on the 
sixth day of admission and discharged on the ninth day.Post-treatment microscopy 
revealed blood films negative for P.vivax.   
 
Discussion 
P. vivax malaria has historically been termed, ‘Benign Tertian Malaria’ but it is 
increasingly felt that this is an erroneous label. Rossle in 1921 described a lethal 
cerebellar haemorrhage in a 21-year old soldier suffering a vivax infection 
(3). Patients presenting with cerebral symptoms such as acute febrile encephalopathy, 
raised intracranial pressure, intracerebral haemorrhage, hemiparesis, aphasia and 
seizures following vivax malaria have been reported previously (4, 5). 
Several cases of cerebral malaria attributed to P.vivax infection have been reported in 
recent years, especially in Asia and South America. This may be due to an overall 
increase in P. vivax malarial infections. Most of these cases have been reported from 
India where P. vivax is the predominant species (6). Although the mechanism by 
which P. vivax causes cerebral malaria is not fully understood, a suggested 
pathogenesis is the sequestration of infected erythrocytes in cerebral microvascular 
beds(7).  
In our case, the peripheral blood smears with Giemsa stain were repeatedly performed 
and parasitaemia remained low. Immuno-chromatography testing showed no trace 
of P. falciparum, and PCR helped confirm mono-infection by P. vivax. Advances in 
molecular and serodiagnosis of malaria parasites have increased the sensitivity and 
specificity, and so the substantial accuracy, of diagnosis of P. vivax. (8, 9) 
Physicians must be aware of the aggressive pathology of severe P. vivax infections 
and institute prompt and accurate diagnosis in treatment. Furthermore, an increasing 
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incidence of severe malaria cases due to P. vivax are already placing a huge burden 
on an already strained healthcare system. 
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